Insufficient scRNA-seq data for expression of CYP11B1 at single-cell level.
Insufficient scRNA-seq data for expression of CYP11B1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 707511.33 | 258 / 258 | 54% | 539.40 | 125 / 230 |
spleen | 76% | 61.74 | 182 / 241 | 0% | 0 | 0 / 0 |
kidney | 72% | 133.33 | 64 / 89 | 0% | 0.03 | 1 / 901 |
bladder | 71% | 43.29 | 15 / 21 | 0% | 0.00 | 1 / 504 |
pancreas | 68% | 50.59 | 223 / 328 | 1% | 3.63 | 1 / 178 |
liver | 67% | 51.84 | 151 / 226 | 0% | 0.01 | 1 / 406 |
uterus | 66% | 85.18 | 112 / 170 | 0% | 0 | 0 / 459 |
ovary | 64% | 57.47 | 115 / 180 | 0% | 0 | 0 / 430 |
stomach | 59% | 67.32 | 212 / 359 | 0% | 0.00 | 1 / 286 |
esophagus | 57% | 54.13 | 826 / 1445 | 1% | 0.01 | 1 / 183 |
prostate | 58% | 74.41 | 141 / 245 | 0% | 0 | 0 / 502 |
intestine | 53% | 38.17 | 513 / 966 | 0% | 0.01 | 1 / 527 |
lung | 48% | 45.42 | 280 / 578 | 0% | 0.32 | 3 / 1155 |
thymus | 47% | 56.39 | 309 / 653 | 0% | 0 | 0 / 605 |
breast | 42% | 32.44 | 194 / 459 | 0% | 0.00 | 1 / 1118 |
blood vessel | 41% | 64.39 | 548 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 40% | 43.51 | 376 / 929 | 0% | 0 | 0 / 0 |
heart | 40% | 42.58 | 344 / 861 | 0% | 0 | 0 / 0 |
brain | 38% | 131.63 | 1011 / 2642 | 0% | 0 | 0 / 705 |
skin | 37% | 37.44 | 670 / 1809 | 1% | 3.84 | 3 / 472 |
adipose | 37% | 38.96 | 441 / 1204 | 0% | 0 | 0 / 0 |
muscle | 34% | 25.45 | 276 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035865 | Biological process | cellular response to potassium ion |
GO_0034650 | Biological process | cortisol metabolic process |
GO_0008217 | Biological process | regulation of blood pressure |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0006704 | Biological process | glucocorticoid biosynthetic process |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0016125 | Biological process | sterol metabolic process |
GO_0006700 | Biological process | C21-steroid hormone biosynthetic process |
GO_0006955 | Biological process | immune response |
GO_0034651 | Biological process | cortisol biosynthetic process |
GO_0071375 | Biological process | cellular response to peptide hormone stimulus |
GO_0032342 | Biological process | aldosterone biosynthetic process |
GO_0042593 | Biological process | glucose homeostasis |
GO_0005739 | Cellular component | mitochondrion |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0047783 | Molecular function | corticosterone 18-monooxygenase activity |
GO_0004507 | Molecular function | steroid 11-beta-monooxygenase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
Gene name | CYP11B1 |
Protein name | Mitochondrial 11beta-hydroxylase Truncated steroid 11beta-hydroxylase Steroid 11-beta-hydroxylase (EC 1.14.15.4) CYP11B1 protein (Cytochrome P450 family 11 subfamily B member 1) Truncated mitochondrial cytochrome P450 11B1 Cytochrome P450 11B1, mitochondrial (CYP11B1) (CYPXIB1) (Cytochrome P-450c11) (Cytochrome P450C11) (Steroid 11-beta-hydroxylase, CYP11B1) (EC 1.14.15.4) Cytochrome P450 family 11 subfamily B member 1 |
Synonyms | S11BH |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the biosynthesis of adrenal corticoids . Catalyzes a variety of reactions that are essential for many species, including detoxification, defense, and the formation of endogenous chemicals like steroid hormones. Steroid 11beta, 18- and 19-hydroxylase with preferred regioselectivity at 11beta, then 18, and lastly 19 (By similarity). Catalyzes the hydroxylation of 11-deoxycortisol and 11-deoxycorticosterone (21-hydroxyprogesterone) at 11beta position, yielding cortisol or corticosterone, respectively, but cannot produce aldosterone . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate for hydroxylation and reducing the second into a water molecule. Two electrons are provided by NADPH via a two-protein mitochondrial transfer system comprising flavoprotein FDXR (adrenodoxin/ferredoxin reductase) and nonheme iron-sulfur protein FDX1 or FDX2 (adrenodoxin/ferredoxin) . Due to its lack of 18-oxidation activity, it is incapable of generating aldosterone . Could also be involved in the androgen metabolic pathway (Probable). . |
Accessions | P15538 ENST00000519285.5 D2KC07 Q8TE40 Q8TE41 ENST00000377675.3 A9UF29 Q8TE38 ENST00000292427.10 [P15538-1] Q4VAR0 Q8TE39 ENST00000517471.5 [P15538-2] H0YBR4 |